NOVNEENovartis AG
127.78CHF+1.56%Mkt Cap: 279.13B $P/E: 22.35

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to tre…

Key Statistics

Company
Market Cap279.13B $
Enterprise Value320.65B $
Revenue (TTM)64.70B $
Gross Profit49.05B $
Net Income (TTM)15.96B $
Revenue/Share33.82 USD
Last Price127.78 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees75.3K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012005267
Valuation
P/E (Trailing)22.35
P/E (Forward)
PEG
EV/EBITDA12.16
EV/Revenue4.96
P/S4.30
P/B7.00
EPS (TTM)5.63
EPS (Forward)
52W Range
108.8482% of range131.82
52W High131.82 CHF
52W Low108.84 CHF
Profitability
Gross Margin75.83%
Oper. Margin34.62%
EBITDA Margin40.74%
Profit Margin24.67%
ROE30.31%
ROA12.60%
Growth
Revenue Growth0.80%
Earnings Growth-17.00%
Cash Flow & Leverage
Operating CF21.85B $
CapEx (TTM)4.45B $
FCF Margin20.99%
FCF Yield4.87%
Net Debt47.25B $
Net Debt/EBITDA1.79
Balance Sheet
Debt/Equity0.77
Current Ratio0.86
Quick Ratio0.55
Book Value/Sh17.90 CHF
Cash/Share4.008 CHF
Dividends
Fwd Div Rate
Trail. Div Rate4.666 CHF
Div. Yield
5Y Avg Yield
Payout Ratio
Ex-Div Date
Pay Date
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.0
Float1.86B
Insiders
Institutions
Technical
SMA 50125.07 (+2.2%)
SMA 200121.45 (+5.2%)
Beta0.49
S&P 52W Chg18.16%
Avg Vol (30d)127.48K
Avg Vol (10d)130.00K
Technical Indicators
RSI (14)50.8
MACD0.0973
MACD Signal0.2566
MACD Hist.-0.1593
BB Upper130.66 CHF
BB Middle126.47 CHF
BB Lower122.28 CHF
BB Width6.62%
ATR (14)2.335 CHF
Vol Ratio (20d)1.03x